HilleVax (HLVX) Competitors $2.04 -0.07 (-3.32%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.04 0.00 (0.00%) As of 08/1/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HLVX vs. TECX, FULC, KOD, ETON, AQST, ITOS, SNDL, VIGL, CMPS, and HUMAShould you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Tectonic Therapeutic (TECX), Fulcrum Therapeutics (FULC), Kodiak Sciences (KOD), Eton Pharmaceuticals (ETON), Aquestive Therapeutics (AQST), iTeos Therapeutics (ITOS), SNDL (SNDL), Vigil Neuroscience (VIGL), COMPASS Pathways (CMPS), and Humacyte (HUMA). These companies are all part of the "pharmaceutical products" industry. HilleVax vs. Its Competitors Tectonic Therapeutic Fulcrum Therapeutics Kodiak Sciences Eton Pharmaceuticals Aquestive Therapeutics iTeos Therapeutics SNDL Vigil Neuroscience COMPASS Pathways Humacyte HilleVax (NASDAQ:HLVX) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Do analysts rate HLVX or TECX? HilleVax presently has a consensus price target of $2.00, indicating a potential downside of 1.96%. Tectonic Therapeutic has a consensus price target of $80.33, indicating a potential upside of 287.52%. Given Tectonic Therapeutic's stronger consensus rating and higher probable upside, analysts plainly believe Tectonic Therapeutic is more favorable than HilleVax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HilleVax 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Which has more risk and volatility, HLVX or TECX? HilleVax has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 3.27, suggesting that its stock price is 227% more volatile than the S&P 500. Does the media favor HLVX or TECX? In the previous week, Tectonic Therapeutic had 3 more articles in the media than HilleVax. MarketBeat recorded 4 mentions for Tectonic Therapeutic and 1 mentions for HilleVax. Tectonic Therapeutic's average media sentiment score of 0.89 beat HilleVax's score of 0.75 indicating that Tectonic Therapeutic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HilleVax 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tectonic Therapeutic 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, HLVX or TECX? Tectonic Therapeutic is trading at a lower price-to-earnings ratio than HilleVax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHilleVaxN/AN/A-$147.27M-$2.15-0.95Tectonic TherapeuticN/AN/A-$57.98M-$7.31-2.84 Do insiders & institutionals believe in HLVX or TECX? 86.4% of HilleVax shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 24.9% of HilleVax shares are owned by company insiders. Comparatively, 38.0% of Tectonic Therapeutic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is HLVX or TECX more profitable? Tectonic Therapeutic's return on equity of -30.13% beat HilleVax's return on equity.Company Net Margins Return on Equity Return on Assets HilleVaxN/A -51.86% -41.45% Tectonic Therapeutic N/A -30.13%-27.52% SummaryTectonic Therapeutic beats HilleVax on 11 of the 14 factors compared between the two stocks. Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLVX vs. The Competition Export to ExcelMetricHilleVaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$105.80M$3.00B$5.48B$9.51BDividend YieldN/A2.43%4.73%4.08%P/E Ratio-0.9517.6228.6723.80Price / SalesN/A179.18373.9066.65Price / CashN/A41.9535.4557.96Price / Book0.668.508.275.55Net Income-$147.27M-$55.06M$3.24B$259.03M7 Day Performance-5.12%-3.98%-3.69%-4.59%1 Month Performance-3.32%9.59%4.33%4.46%1 Year Performance20.00%6.72%25.95%18.03% HilleVax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLVXHilleVax1.8451 of 5 stars$2.04-3.3%$2.00-2.0%+15.3%$105.80MN/A-0.9520News CoveragePositive NewsTECXTectonic Therapeutic2.8726 of 5 stars$22.30-2.0%$80.33+260.3%+16.7%$417.09MN/A-3.06120News CoverageGap UpFULCFulcrum Therapeutics2.2669 of 5 stars$7.53-3.6%$7.43-1.3%-24.2%$403.76M$80M-106.84100Trending NewsEarnings ReportAnalyst UpgradeAnalyst RevisionHigh Trading VolumeKODKodiak Sciences3.3197 of 5 stars$7.60-7.8%$9.00+18.4%+130.1%$401.01MN/A-2.0990Gap DownETONEton Pharmaceuticals1.8975 of 5 stars$14.82-1.4%$29.67+100.2%+289.3%$397.07M$39.01M-82.2520News CoverageUpcoming EarningsAQSTAquestive Therapeutics1.6946 of 5 stars$3.91-2.3%$10.14+159.5%+6.4%$388.88M$57.56M-6.64160Upcoming EarningsITOSiTeos Therapeutics2.9503 of 5 stars$10.110.0%$15.64+54.8%-42.2%$386.72M$35M-3.3290Upcoming EarningsSNDLSNDL2.6343 of 5 stars$1.47-2.3%$4.00+173.0%-25.3%$384.97M$927.61M-5.052,516Trending NewsEarnings ReportVIGLVigil Neuroscience2.7973 of 5 stars$8.07+0.1%$10.80+33.9%+100.7%$384.62MN/A-3.9340Short Interest ↑CMPSCOMPASS Pathways2.6028 of 5 stars$4.06-6.6%$17.00+319.2%-36.9%$379.39MN/A-2.04120News CoverageEarnings ReportAnalyst ForecastGap UpHUMAHumacyte1.7073 of 5 stars$2.45-1.0%$11.71+379.1%-73.5%$379.27M$1.57M-3.54150News CoverageGap Down Related Companies and Tools Related Companies TECX Competitors FULC Competitors KOD Competitors ETON Competitors AQST Competitors ITOS Competitors SNDL Competitors VIGL Competitors CMPS Competitors HUMA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HLVX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLVX Stock Alerts